» Articles » PMID: 7046329

Glucuronidation of Morphine in Human Liver and Interaction with Oxazepam

Overview
Publisher Wiley
Specialty Anesthesiology
Date 1982 Jan 1
PMID 7046329
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Morphine is primarily metabolized through glucuronidation by a microsomal UDP-glucuronyltransferase. With the use of 14C-morphine the activity of this enzyme was measured in hepatic microsomes from ten kidney transplant donors with total cerebral infarction and four icteric patients with pancreatic carcinoma. In the former livers the rate of glucuronidation varied from 1.08 to 8.67 nmol per mg microsomal protein per min, with a mean value of 3.83. These values were somewhat higher than in the liver biopsies from the four cancer patients. Oxazepam, at 1/10 the concentration of morphine, inhibited the morphine glucuronidation by 35%. The inhibition was competitive. Salicylamide also inhibited the morphine glucuronidation but only at concentrations considerably higher than morphine. The relevance of the in vitro data for the in vivo situation is unclear, since the concentrations employed in this study are several-fold higher than those encountered in the plasma of patients treated with these drugs.

Citing Articles

Morphine glucuronidation in human fetal and adult liver.

Pacifici G, Sawe J, Kager L, Rane A Eur J Clin Pharmacol. 1982; 22(6):553-8.

PMID: 6813127 DOI: 10.1007/BF00609630.


Metabolism of narcotics.

McQuay H, Moore A Br Med J (Clin Res Ed). 1984; 288(6412):237.

PMID: 6419875 PMC: 1444476. DOI: 10.1136/bmj.288.6412.237.


Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation.

Sawe J, Kager L, Svensson Eng J, Rane A Br J Clin Pharmacol. 1985; 19(4):495-501.

PMID: 3994897 PMC: 1463820. DOI: 10.1111/j.1365-2125.1985.tb02675.x.


High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.

Sawe J Clin Pharmacokinet. 1986; 11(2):87-106.

PMID: 3514045 DOI: 10.2165/00003088-198611020-00001.


Influence of chronic diflunisal treatment on the plasma levels, metabolism and excretion of indomethacin.

Eriksson L, Liedholm H, Seideman P, Melander A Eur J Clin Pharmacol. 1989; 37(1):7-15.

PMID: 2591467 DOI: 10.1007/BF00609416.